Clinical Study
A Randomized Controlled Trial of Misoprostol and Sulprostone to End Pregnancy after Fetal Death
Table 1
Baseline characteristics (number) of the women included in the analysis.
| Characteristic | Misoprostol | Sulprostone | | () | () |
| Age (mean, SD) | 30.3 (5.2) | 30.3 (4.8) | 20 years | 2 | 1 | 35 years | 10 | 13 |
| Parity | | | Nulliparous | 29 | 30 | Parity 5 | 3 | 2 |
| Previous cesarean section | 4 | 4 |
| Previous miscarriages | | | None | 48 | 46 | 2 | 7 | 4 |
| Gestational age | | | 22 weeks | 38 | 34 | 22–27 weeks | 10 | 11 | 28–36 weeks | 17 | 16 | 37 weeks | 4 | 6 | Uncertain | 1 | 2 | Median | 20.0 | 21.0 | Range | 14.5–40.0 | 14.0–40.5 |
| Duration of fetal death | | | 48 hours | 21 | 19 | 28 days | 6 | 2 | Inaccurate | 28 | 31 |
| Condition of cervix* | | | Closed (dilatation 0 cm) | 55/69 | 51/68 | Length 3 cm | 31/68 | 25/66 | Length 2 cm | 59/68 | 57/66 |
| Ruptured membranes | 5 | 1 |
| Fetal weight | | | 500 g | 39 | 34 | 500–2,499 g | 19 | 19 | 2,500 g | 8 | 6 | Not recorded | 4 | 10 |
|
|
*
Cervical length or dilatation were not recorded for all women.
|